Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-29 Purchase | 2024-06-07 9:45 pm | GENELUX Corp | GNLX | Smither John W Director | 6,250 | $0 | $0 | 19,420 (Direct) | View |
| 2023-09-13 Sale | 2023-09-14 8:18 pm | GENELUX Corp | GNLX | Smither John W Director | 900 | $20.78 | $18,702 | 6,920 (Direct) | View |
| 2021-03-10 Sale | 2021-03-11 3:59 pm | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 1,750 | $32.9 | $57,575 | 178,018 (Indirect Direct) | View |
| 2021-03-01 Sale | 2021-03-03 4:48 pm | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 773 | $34.2 | $26,440 | 112,390 (Indirect Direct) | View |
| 2021-02-10 Sale | 2021-02-12 5:32 pm | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 2,750 | $35.64 | $98,010 | 158,645 (Indirect Direct) | View |
| 2021-02-01 Sale | 2021-02-03 11:23 am | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 5,000 | $35 | $175,000 | 161,395 (Indirect Direct) | View |
| 2021-01-19 Sale | 2021-01-21 4:41 pm | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 1,750 | $30 | $52,500 | 166,395 (Indirect Direct) | View |
| 2020-12-14 Sale | 2020-12-16 3:14 pm | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 5,250 | $30 | $157,500 | 168,145 (Indirect Direct) | View |
| 2020-09-29 Sale | 2020-10-01 9:00 pm | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 1,750 | $30 | $52,500 | 172,072 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-01 Option Award | 2024-08-05 6:34 pm | N/A 2034-07-31 | GENELUX Corp | GNLX | Smither John W Director | 90,010 | $0 | 103,180 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 6:23 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 11,365 | $0 | 152,757 (Direct) | View |
| 2024-02-13 Disposition | 2024-02-15 6:23 pm | N/A 2025-03-31 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 34,097 | $0 | 152,757 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:13 pm | N/A 2034-01-01 | NewAmsterdam Pharma Co N.V. | NAMS | Smither John W Director | 10,000 | $0 | 10,000 (Direct) | View |
Ownership | 2023-12-29 4:30 pm | N/A 2033-01-14 | NewAmsterdam Pharma Co N.V. | NAMS | Smither John W Director | 0 | $0 | 18,600 (Direct) | View |
| 2023-12-27 Disposition | 2023-12-28 5:38 pm | N/A 2032-01-27 | Applied Molecular Transport Inc. | AMTI | Smither John W Director | 100,000 | $0 | 0 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-13 8:14 pm | N/A 2033-09-10 | GENELUX Corp | GNLX | Smither John W Director | 15,367 | $0 | 16,267 (Direct) | View |
Ownership | 2023-09-13 8:13 pm | N/A N/A | GENELUX Corp | GNLX | Smither John W Director | 0 | $0 | 900 (Direct) | View |
| 2023-08-31 Option Award | 2023-09-05 9:38 pm | N/A 2033-08-31 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
Ownership | 2023-09-05 9:36 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 0 | $0 | 253,738 (Indirect) | View |
| 2023-06-22 Option Award | 2023-06-22 8:16 pm | N/A 2033-06-21 | eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 5:28 pm | N/A 2033-06-14 | Applied Molecular Transport Inc. | AMTI | Smither John W Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:15 pm | N/A 2033-01-19 | eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director | 36,875 | $0 | 36,875 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 6:51 pm | N/A 2032-06-08 | eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 5:23 pm | N/A 2032-05-24 | Applied Molecular Transport Inc. | AMTI | Smither John W Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 5:39 pm | 2022-02-27 2032-01-27 | Applied Molecular Transport Inc. | AMTI | Smither John W Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-10-06 Option Award | 2021-10-08 5:18 pm | N/A 2031-10-05 | eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-08-25 Option Award | 2021-08-27 6:26 pm | N/A 2028-03-26 | eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director | 27,698 | $0 | 51,840 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-11 3:59 pm | N/A 2029-05-14 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 500 | $0 | 178,018 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-11 3:59 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 500 | $1.6806 | 178,018 (Direct) | View |
| 2021-03-03 Option Award | 2021-03-05 3:55 pm | N/A 2031-03-03 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 38,300 | $0 | 260,770 (Direct) | View |
| 2021-03-04 Exercise | 2021-03-05 3:55 pm | N/A 2029-05-14 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 12,396 | $0 | 260,770 (Direct) | View |
| 2021-03-04 Exercise | 2021-03-05 3:55 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 12,396 | $1.6806 | 260,770 (Direct) | View |
| 2021-02-10 Exercise | 2021-02-12 5:32 pm | N/A 2029-05-14 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 750 | $0 | 158,645 (Direct) | View |
| 2021-02-10 Exercise | 2021-02-12 5:32 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 750 | $1.6806 | 158,645 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-03 11:23 am | N/A 2029-05-14 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 1,250 | $0 | 161,395 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-03 11:23 am | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 1,250 | $1.6806 | 161,395 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-21 4:41 pm | N/A 2029-05-14 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 500 | $0 | 166,395 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-21 4:41 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 500 | $1.6806 | 166,395 (Direct) | View |
| 2020-12-14 Exercise | 2020-12-16 3:14 pm | N/A 2029-05-14 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 1,500 | $0 | 168,145 (Direct) | View |
| 2020-12-14 Exercise | 2020-12-16 3:14 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 1,500 | $1.6806 | 168,145 (Direct) | View |
| 2020-09-29 Exercise | 2020-10-01 9:00 pm | N/A 2029-05-14 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 500 | $0 | 172,072 (Direct) | View |
| 2020-09-29 Exercise | 2020-10-01 9:00 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 500 | $1.6806 | 172,072 (Direct) | View |
| 2020-06-11 Exercise | 2020-06-15 3:15 pm | N/A 2029-05-14 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 14,875 | $0 | 233,920 (Direct) | View |
| 2020-06-11 Exercise | 2020-06-15 3:15 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 14,875 | $1.6806 | 233,920 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 9:09 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 21,000 | $0 | 120,965 (Direct) | View |
Ownership | 2020-01-30 8:00 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 0 | $0 | 289,896 (Direct) | View |